(P-2036) Obeldesivir for Treatment of COVID-19 in Adults and Adolescents Without Risk Factors for Progression to Severe Disease: the OAKTREE Study

Saturday, October 19, 2024

12:15 PM – 1:30 PM US PT

Location: Halls JK

Presenting Author(s)

Onyema Ogbuagu, MD

Associate Professor and Director, Antivirals and vaccines research Program
Yale School of Medicine
Cheshire, CT, United States

Co-Author(s)

Jason D. Goldman, MD, MPH (he/him/his)

Physician, Infectious Disease
Swedish Medical Center, Seattle, WA, USA, and Division of Allergy and Infectious Diseases, University of Washington
Seattle, WA, United States
RG

Robert L. Gottlieb, MD

Practicing Physician
Baylor University Medical Center
Dallas, Texas, United States
Upinder Singh, MD, FIDSA

Professor and Division Chief
Stanford University, CA, United States
MS

Masaharu Shinkai, MD, PhD

Tokyo Shinagawa Hospital
Tokyo, Tokyo, Japan
GA

Gerard Acloque, MD

Universal Medical and Research Center, LLC
Coral Gables, Florida, United States
DF

Dahlene Fusco, MD, PhD

Tulane School of Medicine
New Orleans, Louisiana, United States
EG

Erika Gonzalez, MD

STAAMP Research
San Antonio, Texas, United States
Princy N. Kumar, MD

Professor, Medicine; Chief, Division of Infectious Diseases and Travel Medicine
Georgetown University Medical Center, Washington, DC, USA
Washington, District of Columbia, United States
Annie Luetkemeyer, MD (she/her/hers)

Professor of Medicine
University of California San Francisco
San Francisco, CA, United States
AL

Amos Lichtman, MPH, MD

Gilead Sciences, Inc.
Foster City, California, United States
AM

Afsaneh Mozaffarian, MS

Gilead Sciences, Inc.
Foster City, California, United States
YK

Yiannis Koullias, MD

Gilead Sciences, Inc.
Foster City, California, United States
RH

Robert H. Hyland, DPhil

Gilead Sciences, Inc.
Foster City, California, United States
JL

Joe Llewellyn, PharmD (he/him/his)

Clinical Development
Gilead Sciences, Inc.
Foster City, California, United States
AO

Anu Osinusi, MD

Clinical Research
Gilead
Foster City, California, United States
FD

Frank Duff, MD

Senior Vice President
Gilead Sciences, Inc
San Francisco, California, United States
RH

Rita Humeniuk, PhD

Gilead Sciences, Inc.
Foster City, California, United States
LC

Luzelena Caro, PhD

Gilead Sciences, Inc.
Foster City, California, United States
SD

Santosh Davies, MD

Gilead Sciences, Inc.
Foster City, California, United States
Charlotte Hedskog, PhD (she/her/hers)

Senior Research Scientist
Gilead Sciences, Inc.
Foster City, California, United States
SC

Shuguang Chen, PhD

Director
Gilead Sciences, Inc
Foster City, California, United States
KE

Kim Etchevers, MS

Gilead Sciences, Inc.
Foster City, California, United States
PN

Priyanka Nadig, MPH

Gilead Sciences, Inc.
Foster City, California, United States
AK

Anita Kohli, MD

Arizona Liver Health
Tucson, Arizona, United States